Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CTVA | HBM |
|---|---|---|
| Price | $12.28 | $26.21 |
| Change today | ▼ 84.19% | ▼ 1.78% |
| Market cap | $8.19B | $11.64B |
| Return, 3 months | – | +16.0% |
| Return, year to date | – | +32.1% |
| Return, 1 year | – | +70.6% |
| P/E (TTM) | 8.0 | 16.1 |
| P/B | 0.3 | 3.3 |
| P/E percentile vs own 5y | 81st | – |
| Dividend yield | 5.86% | 0.08% |
| Revenue growth (YoY, latest qtr) | -1.2% | – |
| Net profit growth (YoY) | -11.5% | – |
| Gross margin | 49.5% | – |
| Operating margin | 17.0% | – |
| Net margin | 5.7% | – |
| Return on equity | 4.0% | – |
| Analyst target vs. price | +666.7% | +21.8% |
| Analyst buy share | 71% | 100% |
| RSI (14) | – | 49 |
| 30-day volatility | – | 52.0% |
| Max drawdown, 1 year | – | -36.2% |
| Trend read | – | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
